Your browser doesn't support javascript.
loading
Structure-based identification of potential SARS-CoV-2 main protease inhibitors.
Khan, Shama; Fakhar, Zeynab; Hussain, Afzal; Ahmad, Aijaz; Jairajpuri, Deeba Shamim; Alajmi, Mohamed F; Hassan, Md Imtaiyaz.
Affiliation
  • Khan S; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Fakhar Z; Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Johannesburg, South Africa.
  • Hussain A; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Ahmad A; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Jairajpuri DS; National Health Laboratory Service, Infection Control, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Alajmi MF; Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
  • Hassan MI; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
J Biomol Struct Dyn ; 40(8): 3595-3608, 2022 05.
Article in En | MEDLINE | ID: mdl-33210561
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / COVID-19 Drug Treatment Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2022 Type: Article Affiliation country: South Africa
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / COVID-19 Drug Treatment Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2022 Type: Article Affiliation country: South Africa